Nanocarriers for the treatment of glioblastoma multiforme: A succinct review of conventional and repositioned drugs in the last decade
Archiv der Pharmazie · 2024
DOI: 10.1002/ardp.202400343 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Archiv der Pharmazie, 2024. Verfasst von Mahitab Bayoumi und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmaceutics and Pharmaceutical Technology, Faculty of Pharmacy, The British University in Egypt, Cairo, Egypt. Hauptthemen laut MEDLINE: Glioblastoma, Brain Neoplasms, Antineoplastic Agents, Drug Carriers. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 189 Literaturangaben. Gefördert von: None.
Abstract (Originalsprache)
Glioblastoma multiforme is a very combative and threatening type of cancer. The standard course of treatment involves excising the tumor surgically, then administering chemotherapy and radiation therapy. Because of the presence of the blood–brain barrier and the unique characteristics of the tumor microenvironment, chemotherapy is extremely difficult and has a high incidence of relapse. With their capacity to precisely target and transport therapeutic medications to the tumor while overcoming the challenges provided by invasive and infiltrative gliomas, nanocarriers offer a potentially beneficial treatment option for gliomas. Drug repositioning or, in other words, finding novel therapeutic uses for medications that have received approval for previous uses has also recently emerged to provide alternative treatments for many diseases, with glioblastoma being among them. In this article, our goal is to shed light on the pathogenesis of glioma and summarize the proposed treatment approaches in the last decade, highlighting how combining repositioned drugs and nanocarriers technology can reduce drug resistance and improve therapeutic efficacy in primary glioma.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pharmaceutics and Pharmaceutical Technology, Faculty of Pharmacy, The British University in Egypt, Cairo, Egypt.
- Department of Pharmaceutics and Industrial Pharmacy, Faculty of Pharmacy, Ain Shams University, Cairo, Egypt.
- Chemotherapeutic Unit, Mansoura University Hospitals, Mansoura, Egypt.
- Nanotechnology Research Center, The British University in Egypt, Cairo, Egypt.
Förderung
- None
Zitieren
APA
Bayoumi, M., Youshia, J., Arafa, M. G., Nasr, M., & Sammour, O. A. (2024). Nanocarriers for the treatment of glioblastoma multiforme: A succinct review of conventional and repositioned drugs in the last decade. Archiv der Pharmazie. https://doi.org/10.1002/ardp.202400343
Vancouver
Bayoumi M, Youshia J, Arafa MG, Nasr M, Sammour OA. Nanocarriers for the treatment of glioblastoma multiforme: A succinct review of conventional and repositioned drugs in the last decade. Archiv der Pharmazie. 2024. doi:10.1002/ardp.202400343
BibTeX
@article{Bayoumi2024,
author = {Bayoumi, Mahitab and Youshia, John and Arafa, Mona G and Nasr, Maha and Sammour, Omaima A},
title = {Nanocarriers for the treatment of glioblastoma multiforme: A succinct review of conventional and repositioned drugs in the last decade},
journal = {Archiv der Pharmazie},
year = {2024},
doi = {10.1002/ardp.202400343}
}
EUVIMED